UM-164: a potent c-Src/p38 kinase inhibitor with in vivo...

  • Main
  • 2016 / 05
  • UM-164: a potent c-Src/p38 kinase inhibitor with in vivo...
Clinical Cancer Research 2016 / 05

UM-164: a potent c-Src/p38 kinase inhibitor with in vivo activity against triple negative breast cancer

Gilani, R., Phadke, S., Bao, L. W., Lachacz, E., Dziubinski, M., Brandvold, K., Steffey, M., Kwarcinski, F., Graveel, C. R., Kidwell, K. M., Merajver, S. D., Soellner, M. B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-15-2158
Date:
May, 2016
File:
PDF, 13.79 MB
english, 2016
Conversion to is in progress
Conversion to is failed